Patents by Inventor Michelle SPATARA

Michelle SPATARA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20220380452
    Abstract: The present disclosure relates to compositions for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: August 5, 2022
    Publication date: December 1, 2022
    Inventors: Myrna A. MONCK, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • Biopharmaceutical compositions
    Patent number: 11459384
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: October 4, 2022
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED
    Inventors: Myrna A. Monck, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20220185878
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: March 2, 2022
    Publication date: June 16, 2022
    Inventors: Myrna A. MONCK, Narendra B. BAM, Jennifer DALLY, Michelle SPATARA
  • Biopharmaceutical compositions
    Patent number: 11299541
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: April 12, 2022
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    Inventors: Myrna A. Monck, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • Biopharmaceutical compositions
    Patent number: 11286298
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: March 29, 2022
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED
    Inventors: Myrna A. Monck, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • Biopharmaceutical compositions
    Patent number: 11274148
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: March 15, 2022
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    Inventors: Myrna A. Monck, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20210340247
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: July 12, 2021
    Publication date: November 4, 2021
    Inventors: Myrna A. MONCK, Narendra B. BAM, Jennifer DALLY, Michelle SPATARA
  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20210340246
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: July 12, 2021
    Publication date: November 4, 2021
    Inventors: Myrna A. MONCK, Narendra B. BAM, Jennifer DALLY, Michelle SPATARA
  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20210332125
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: July 12, 2021
    Publication date: October 28, 2021
    Inventors: Myrna A. Monck, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • Biopharmaceutical compositions comprising interleukin-5 antibody
    Patent number: 10870695
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: December 22, 2020
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED
    Inventors: Myrna A. Monck, Narendra B. Bam, Jennifer Dally, Michelle Spatara
  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20200199219
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: March 2, 2020
    Publication date: June 25, 2020
    Inventors: Myrna A. MONCK, Narendra B. BAM, Jennifer DALLY, Michelle SPATARA
  • BIOPHARMACEUTICAL COMPOSITIONS
    Publication number: 20180251539
    Abstract: The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
    Type: Application
    Filed: August 22, 2016
    Publication date: September 6, 2018
    Inventors: Myrna A. MONCK, Narendra B. BAM, Jennifer DALLY, Michelle SPATARA